General Session 1 includes results from EMBER-3 and OlympiA phase III trials

Komal L. Jhaveri, MD; Matteo Lambertini, MD, PhD; and Judy E. Garber, MD, MPH, were among the experts presenting findings from six studies Wednesday during the first General Session of the 2024 San Antonio Breast Cancer Symposium®.